ESR1 and breast carcinoma: Interestingly, while estrogen-positive breast cancer cells seemed to be more impacted by treatment with MeG, there were no significant changes in the expression of estrogen receptor 1 or 2 and no significant impact on estrogen-dependent cancer signaling in MCF-7 cells treated with MeG (IC50).